MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$9,442K
EPS
-$0.08
Unit: Thousand (K) dollars

Income Statement
2026-06-30
2026-03-31
2025-12-31
Research and development
4,262 4,552 3,329*
General and administrative
5,117 4,729 3,853*
Total operating expenses
9,379 9,281 7,181
Loss from operations
-9,379 -9,281 -7,181*
Change in fair value of warrant derivative
0 0 -38*
Fair value loss from standby equity purchase agreement (sepa arrangement)
0 --97*
Foreign exchange gain (loss)
1 -6 -26*
Interest income
37 44 97*
Total other income, net
38 38 11*
Loss before income taxes
-9,341 --7,170*
Income tax expense
101 -20*
Net loss
-9,442 -9,243 -7,190*
Translation adjustments
0 0 -34*
Comprehensive loss
-9,442 -9,243 -7,224
Basic EPS
-0.08 -0.08 -0.075
Diluted EPS
-0.08 -0.08 -0.075
Basic Average Shares
119,739,942 112,292,579 95,857,147
Diluted Average Shares
119,739,942 112,292,579 95,857,147
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive loss-$9,442K Net loss-$9,442K Interest income$37K Foreign exchange gain(loss)$1K Loss before incometaxes-$9,341K Income tax expense$101K Total other income,net$38K Loss from operations-$9,379K Total operatingexpenses$9,379K General andadministrative$5,117K Research and development$4,262K

ONCOLYTICS BIOTECH INC (ONCY)

ONCOLYTICS BIOTECH INC (ONCY)